par Klastersky, Jean
;Rapoport, Bernardo Leon B.;Aapro, Matty;Feld, Ronald
Référence The MASCC Textbook of Cancer Supportive Care and Survivorship, Springer Science+Business Media, page (337-348)
Publication Publié, 2018-01
;Rapoport, Bernardo Leon B.;Aapro, Matty;Feld, RonaldRéférence The MASCC Textbook of Cancer Supportive Care and Survivorship, Springer Science+Business Media, page (337-348)
Publication Publié, 2018-01
Partie d'ouvrage collectif
| Résumé : | Infections are major causes of morbidity and mortality in cancer patients. The risk of infection is determined by the intensity and duration of myelosuppressive and/or immunosuppressive chemotherapy. In patients with hematological malignancies, the underlining malignancy itself may be associated with neutropenia and/or immune defects. In solid tumors, anatomical factors may predispose patients to infection. Other predisposing factors include intravenous devices, neutropenia, mucosal integrity, treatment with corticosteroids, usage of monoclonal antibodies, splenic function, and treatment with chemotherapy or radiation therapy. Patients with neutropenic fever often have an established or an occult infection. Patients with neutropenia are at the highest risk of severe infections although prevention is possible in >50% of the cases through the use of G-CSF (granulocyte colony-stimulating factors). Bacteremia is documented in approximately a quarter of the patients with febrile neutropenia. In terms of risk assessment, the MASCC (Multinational Association of Supportive Care in Cancer) has pioneered and developed an index that predicts for high risk or low risk of medical complications which helps in tailoring the most appropriate management for these patients. |



